Regulation of fatty acid synthesis and oxidation by the AMP-activated protein kinase
- PMID: 12440973
- DOI: 10.1042/bst0301064
Regulation of fatty acid synthesis and oxidation by the AMP-activated protein kinase
Abstract
The AMP-activated protein kinase (AMPK) is a sensor of cellular energy charge and a 'metabolic master switch'. When activated by ATP depletion, it switches off ATP-consuming processes, while switching on catabolic pathways that generate ATP. AMPK exists as heterotrimeric complexes comprising catalytic alpha subunits and regulatory beta and gamma subunits, each of which occurs as multiple isoforms. Rising AMP and falling ATP, brought about by various types of cellular stress (including exercise in skeletal muscle), stimulate the system in an ultrasensitive manner. Acetyl-CoA carboxylase (ACC) exists in mammals as two isoforms, termed ACC-1 and ACC-2 (also known as ACC-alpha and ACC-beta). AMPK phosphorylates and inactivates both isoforms at the equivalent site. Knockout mice, and other approaches, suggest that the malonyl-CoA produced by ACC-2 is exclusively involved in regulation of fatty acid oxidation, whereas that produced by ACC-1 is utilized in fatty acid synthesis. Activation of AMPK by cellular stress or exercise therefore switches on fatty acid oxidation (via phosphorylation of ACC-2) while switching off fatty acid synthesis (via phosphorylation of ACC-1). The Drosophila melanogaster genome contains single genes encoding homologues of the alpha, beta and gamma subunits of AMPK (DmAMPK) and of ACC (DmACC). Studies in a Drosophila embryonal cell line show that DmAMPK is activated by stresses that cause ATP depletion (oligomycin, hypoxia or glucose deprivation) and that this is associated with phosphorylation of the site on DmACC equivalent to the AMPK sites on mammalian ACC-1 and ACC-2. This is abolished when expression of DmAMPK is ablated using an RNA interference approach, proving that DmAMPK is necessary for phosphorylation of DmACC in response to ATP depletion.
Similar articles
-
AMP-activated protein kinase regulation of fatty acid oxidation in the ischaemic heart.Biochem Soc Trans. 2003 Feb;31(Pt 1):207-12. doi: 10.1042/bst0310207. Biochem Soc Trans. 2003. PMID: 12546686 Review.
-
Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: acetyl-CoA carboxylase inhibition and AMP-activated protein kinase activation.Proc Natl Acad Sci U S A. 2002 Dec 10;99(25):16309-13. doi: 10.1073/pnas.222657499. Epub 2002 Nov 27. Proc Natl Acad Sci U S A. 2002. PMID: 12456889 Free PMC article.
-
Control of p70 ribosomal protein S6 kinase and acetyl-CoA carboxylase by AMP-activated protein kinase and protein phosphatases in isolated hepatocytes.Eur J Biochem. 2002 Aug;269(15):3751-9. doi: 10.1046/j.1432-1033.2002.03074.x. Eur J Biochem. 2002. PMID: 12153572
-
A homologue of AMP-activated protein kinase in Drosophila melanogaster is sensitive to AMP and is activated by ATP depletion.Biochem J. 2002 Oct 1;367(Pt 1):179-86. doi: 10.1042/BJ20020703. Biochem J. 2002. PMID: 12093363 Free PMC article.
-
The AMP-activated protein kinase--fuel gauge of the mammalian cell?Eur J Biochem. 1997 Jun 1;246(2):259-73. doi: 10.1111/j.1432-1033.1997.00259.x. Eur J Biochem. 1997. PMID: 9208914 Review.
Cited by
-
Effect of Metformin on Sertoli Cell Fatty Acid Metabolism and Blood-Testis Barrier Formation.Biology (Basel). 2024 May 9;13(5):330. doi: 10.3390/biology13050330. Biology (Basel). 2024. PMID: 38785812 Free PMC article.
-
Hydroxytyrosol Linoleoyl Ether Ameliorates Metabolic-Associated Fatty Liver Disease Symptoms in Obese Zucker Rats.ACS Pharmacol Transl Sci. 2024 Apr 4;7(5):1571-1583. doi: 10.1021/acsptsci.4c00105. eCollection 2024 May 10. ACS Pharmacol Transl Sci. 2024. PMID: 38751648
-
Upregulated Matrisomal Proteins and Extracellular Matrix Mechanosignaling Underlie Obesity-Associated Promotion of Pancreatic Ductal Adenocarcinoma.Cancers (Basel). 2024 Apr 21;16(8):1593. doi: 10.3390/cancers16081593. Cancers (Basel). 2024. PMID: 38672675 Free PMC article.
-
AMPK Signaling Pathway as a Potential Therapeutic Target for Parkinson's Disease.Adv Pharm Bull. 2024 Mar;14(1):120-131. doi: 10.34172/apb.2024.013. Epub 2023 Oct 14. Adv Pharm Bull. 2024. PMID: 38585465 Free PMC article. Review.
-
CDK6 inhibits de novo lipogenesis in white adipose tissues but not in the liver.Nat Commun. 2024 Feb 5;15(1):1091. doi: 10.1038/s41467-024-45294-z. Nat Commun. 2024. PMID: 38316780 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous